1. Home
  2. HDL vs DNA Comparison

HDL vs DNA Comparison

Compare HDL & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HDL

SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

HOLD

Current Price

$12.66

Market Cap

723.1M

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.03

Market Cap

599.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDL
DNA
Founded
2016
2008
Country
Singapore
United States
Employees
14003
485
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
723.1M
599.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HDL
DNA
Price
$12.66
$9.03
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
1.3K
1.1M
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.73
N/A
Revenue Next Year
$12.94
N/A
P/E Ratio
$55.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.00
$5.37
52 Week High
$21.21
$17.58

Technical Indicators

Market Signals
Indicator
HDL
DNA
Relative Strength Index (RSI) 44.64 47.93
Support Level $12.00 $7.59
Resistance Level $13.73 $10.05
Average True Range (ATR) 0.13 0.83
MACD 0.03 -0.12
Stochastic Oscillator 38.15 11.72

Price Performance

Historical Comparison
HDL
DNA

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company, and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: